Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.7503
-0.0296 (-3.80%)
At close: Jun 13, 2025, 4:00 PM
0.7599
+0.0096 (1.28%)
After-hours: Jun 13, 2025, 6:05 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $62.06 million as of June 13, 2025. Its market cap has decreased by -47.92% in one year.
Market Cap
62.06M
Enterprise Value
-72.14M
1-Year Change
-47.92%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $62.06M, a decrease of -79.43%. That is a compound annual growth rate of -28.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 62.06M | -21.71% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |